These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25534297)

  • 1. Adherence to malaria prophylaxis among Peace Corps Volunteers in the Africa region, 2013.
    Landman KZ; Tan KR; Arguin PM
    Travel Med Infect Dis; 2015; 13(1):61-8. PubMed ID: 25534297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014.
    Tan KR; Henderson SJ; Williamson J; Ferguson RW; Wilkinson TM; Jung P; Arguin PM
    Travel Med Infect Dis; 2017; 17():50-55. PubMed ID: 28487213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013.
    Landman KZ; Tan KR; Arguin PM;
    MMWR Morb Mortal Wkly Rep; 2014 Jun; 63(23):516-7. PubMed ID: 24918487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N; D'Acremont V; Landry P; Genton B
    Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to malaria prophylaxis among travelers from a middle-income country.
    Rodrigues KMP; Costa ABFD; Santoro-Lopes G
    Rev Soc Bras Med Trop; 2019 Jun; 52():e20190014. PubMed ID: 31188918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic use of antimalarials during pregnancy.
    Irvine MH; Einarson A; Bozzo P
    Can Fam Physician; 2011 Nov; 57(11):1279-81. PubMed ID: 22084457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers.
    Korhonen C; Peterson K; Bruder C; Jung P
    Am J Prev Med; 2007 Sep; 33(3):194-9. PubMed ID: 17826578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malaria--chemoprophylaxis 2001].
    Hatz FR; Beck B; Blum J; Funk M; Furrer H; Genton B; Holzer B; Loutan L; Markwalder K; Raeber PA; Schlagenhauf P; Siegl G; Steffen R; Stürchler D; Wyss R
    Ther Umsch; 2001 Jun; 58(6):347-51. PubMed ID: 11441694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ; Koene HR; Spong K; Overbosch D
    J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006.
    Andersson H; Askling HH; Falck B; Rombo L
    Mil Med; 2008 Dec; 173(12):1194-8. PubMed ID: 19149338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.
    DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA
    J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITHDRAWN: Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2015 Oct; (10):CD006491. PubMed ID: 26436859
    [No Abstract]   [Full Text] [Related]  

  • 20. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.
    Carme B; Peguet C; Nevez G
    Trop Med Int Health; 1997 Oct; 2(10):953-6. PubMed ID: 9357484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.